MedStar Authors catalog › Details for: Late-breaking Trials from the 2016 American Heart Association's Scientific Sessions.
Normal view MARC view ISBD view

Late-breaking Trials from the 2016 American Heart Association's Scientific Sessions.

by Buchanan, Kyle; Alraies, M Chadi; Kajita, Alexandre H; Rogers, Toby; Koifman, Edward; Steinvil, Arie.
Citation: Cardiovascular Revascularization Medicine. 18(1):70-74, 2017 Jan - Feb.Journal: Cardiovascular revascularization medicine : including molecular interventions.Published: 2017ISSN: 1878-0938.Full author list: Buchanan KD; Alraies MC; Kajita AH; Rogers T; Koifman E; Steinvil A.UI/PMID: 28131332.Subject(s): *Biomedical Research | *Cardiology | Cardiovascular Diseases/di [Diagnosis] | Cardiovascular Diseases/mo [Mortality] | Cardiovascular Diseases/pp [Physiopathology] | *Cardiovascular Diseases/th [Therapy] | Clinical Trials as Topic | Humans | Treatment OutcomeInstitution(s): MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): CongressesDigital Object Identifier: https://dx.doi.org/10.1016/j.carrev.2016.12.002 (Click here) Abbreviated citation: Cardiovasc Revasc Med. 18(1):70-74, 2017 Jan - Feb.Local Holdings: Available in print through MWHC library: 2002 - present.Abstract: The late breaking trials released at the American Heart Association scientific sessions conference in November in New Orleans, LA covered a wide range of topics, including new devices within the field of heart failure, new registry data on transcatheter aortic valve replacement (TAVR) in intermediate risk patients, and medical management of peripheral arterial disease, coronary artery disease, and hypercholesterolemia. The following review highlights the late breaking trials presented at the conference that will have significant impact on clinical practice.Abstract: Copyright © 2016. Published by Elsevier Inc.

Powered by Koha